Chartash; Elliot Keith

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chartash; Elliot Keith.The latest application filed is for "multiple-variable dose regimen for treating tnfalpha-related disorders".

Company Profile

1.4.15

Chartash; Elliot Keith - Randolph NJ
CHARTASH; Elliot Keith - Rahway NJ
Chartash; Elliot Keith - Marietta GA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS App 20210347875 - Hoffman; Rebecca S. ; et al.	2021-11-11
MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS App 20190055308 - Hoffman; Rebecca S. ; et al.	2019-02-21
Combination Of An Anti-il-10 Antibody And A Cpg-c Type Oligonucleotide For Treating Cancer App 20180161427 - YU; Ying ; et al.	2018-06-14
MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS App 20170044249 - Hoffman; Rebecca S. ; et al.	2017-02-16
Methods for treating psoriasis by administering an antibody which binds an epitope of the p40 subunit of IL-12 and/or IL-23 Grant 9,051,368 - Chartash , et al. June 9, 2	2015-06-09
Multiple-variable dose regimen for treating TNF.alpha.-related disorders Grant 8,961,974 - Hoffman , et al. February 24, 2	2015-02-24
Multiple-variable dose regimen for treating TNF.alpha.-related disorders Grant 8,961,973 - Hoffman , et al. February 24, 2	2015-02-24
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders App 20140255396 - Hoffman; Rebecca S. ; et al.	2014-09-11
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders App 20140248277 - Hoffman; Rebecca S. ; et al.	2014-09-04
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders App 20140248275 - Hoffman; Rebecca S. ; et al.	2014-09-04
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders App 20140248276 - Hoffman; Rebecca S. ; et al.	2014-09-04
Multiple-variable Dose Regimen For Treating Tnfalpha-related Disorders App 20140212430 - Hoffman; Rebecca S. ; et al.	2014-07-31
TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIES App 20130243763 - Banerjee; Subhashis ; et al.	2013-09-19
Treatment of spondyloarthropathies using TNFalpha inhibitors App 20070202104 - Banerjee; Subhashis ; et al.	2007-08-30
Treatment of vasculitides using TNFalpha inhibitors App 20040136989 - Banerjee, Subhashis ; et al.	2004-07-15
Treatment of pulmonary disorders using TNFalpha inhibitor App 20040131614 - Banerjee, Subhashis ; et al.	2004-07-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.